Bottom line
How much do GGHCX and QAAGZX overlap?
57% of their top holdings overlap by weight. 11 securities appear in both funds' top 25, making up 46.0% of GGHCX's assets and 46.5% of QAAGZX's. They share a meaningful core but differ in the rest of the portfolio.
QAAGZX holds far more positions (277 vs 82), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings GGHCX and QAAGZX have in common
| Holding | % of GGHCX | % of QAAGZX | Overlap |
|---|---|---|---|
| Eli Lilly and Co. | 10.59% | 14.06% | 10.59% |
| Johnson & Johnson | 6.76% | 6.64% | 6.64% |
| UnitedHealth Group Inc. | 6.17% | 5.88% | 5.88% |
| Merck & Co., Inc. | 4.59% | 4.00% | 4.00% |
| AbbVie Inc. | 4.03% | 5.12% | 4.03% |
| Gilead Sciences, Inc. | 3.63% | 2.79% | 2.79% |
| CVS Health Corp. | 2.52% | 0.93% | 0.93% |
| Cardinal Health, Inc. | 2.10% | 1.04% | 1.04% |
| Guardant Health, Inc. | 2.04% | 1.22% | 1.22% |
| Vertex Pharmaceuticals Inc. | 2.01% | 2.26% | 2.01% |
| Thermo Fisher Scientific Inc. | 1.55% | 2.53% | 1.55% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in GGHCX
- Invesco Private Prime Fund — 4.67%
- argenx SE — 3.24%
- Welltower Inc. — 2.34%
- BrightSpring Health Services, Inc. — 2.20%
- Royalty Pharma PLC — 2.13%
- Invesco Private Government Fund — 1.80%
- Axsome Therapeutics, Inc. — 1.58%
- Edwards Lifesciences Corp. — 1.56%
- Invesco Treasury Portfolio — 1.56%
- BridgeBio Pharma, Inc. — 1.43%
- Waters Corp. — 1.41%
- IQVIA Holdings Inc. — 1.32%
- U C B S.a. — 1.24%
- Ligand Pharmaceuticals Inc. — 1.18%
Only in QAAGZX
- Bristol-myers Squibb Co — 2.12%
- Abbott Laboratories — 1.91%
- Intuitive Surgical Inc — 1.89%
- Amgen Inc — 1.80%
- Stryker Corp — 1.78%
- Elevance Health Inc — 1.54%
- Danaher Corp — 1.44%
- Natera Inc — 1.44%
- Royalty Pharma Plc- Cl A — 0.97%
- Tenet Healthcare Corp — 0.94%
- Kymera Therapeutics Inc — 0.89%
- T. Rowe Price Government Reserve Fund — 0.87%
- Protagonist Therapeutics Inc — 0.85%
- Moderna Therapeutics Inc — 0.83%
Asset mix
| Asset type | GGHCX | QAAGZX |
|---|---|---|
| Stocks | 97.5% | 96.9% |
| Cash & short-term funds | 8.8% | 0.9% |
| Preferred stock | — | 2.2% |
| Bonds | — | 0.1% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Country mix
| Country | GGHCX | QAAGZX |
|---|---|---|
| US | 93.5% | 92.3% |
| NL | 3.4% | 1.0% |
| GB | 3.1% | 1.8% |
| CH | 2.7% | 0.5% |
| BE | 1.2% | — |
| DK | 1.1% | 0.7% |
| IE | 0.6% | 0.8% |
| BM | — | 0.7% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do GGHCX and QAAGZX overlap?
What stocks do GGHCX and QAAGZX have in common?
Should I own both GGHCX and QAAGZX?
Which holds more stocks, GGHCX or QAAGZX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.